Nanjing Hicin Pharmaceutical Co., Ltd. (SHE:300584)

SHE:300584 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	51.24	45.76	46.82	95.07	115.6	103.23
Trading Asset Securities	-	-	-	-	-	10
Cash & Short-Term Investments	51.24	45.76	46.82	95.07	115.6	113.23
Cash Growth	157.82%	-2.27%	-50.75%	-17.76%	2.09%	-24.57%
Accounts Receivable	156.6	200.56	207.7	190.71	113.31	101.69
Other Receivables	27.96	0.08	0.13	18.24	10.48	5.57
Receivables	184.56	200.64	207.82	208.95	123.79	107.26
Inventory	86.6	85.67	81.46	64.13	55.16	71.58
Prepaid Expenses	-	-	-	0.23	0.23	0.16
Other Current Assets	17.48	25.08	41.19	9.99	7.17	1.52
Total Current Assets	339.88	357.15	377.3	378.38	301.96	293.74
Property, Plant & Equipment	801.58	763.73	646.76	505.53	370.75	310.81
Long-Term Investments	139.55	131.46	131.46	190.7	437.58	129.95
Other Intangible Assets	131.75	140.8	126.77	134.01	122.33	92.23
Long-Term Deferred Tax Assets	26.15	25.49	21.84	16.6	11.76	8.38
Long-Term Deferred Charges	11.32	10.6	41.54	37.32	50.59	52.51
Other Long-Term Assets	28.99	35.31	63.21	31.4	7.04	18.9
Total Assets	1,479	1,465	1,409	1,294	1,302	906.52
Accounts Payable	37.66	33.74	63.95	59.89	80.26	20.69
Accrued Expenses	0.37	31.83	28.61	20.81	17.05	14.92
Short-Term Debt	219.57	230.26	252.98	120.1	100.11	70.08
Current Portion of Long-Term Debt	22.56	12.18	18.02	58.06	80.09	60.74
Current Portion of Leases	-	-	-	-	0.08	-
Current Income Taxes Payable	15.99	2.12	5.38	17.16	0.98	0.71
Current Unearned Revenue	1.99	2.35	3.36	1.74	7.21	4.81
Other Current Liabilities	37.85	22.88	27.97	39.29	15.64	9.03
Total Current Liabilities	335.99	335.35	400.27	317.05	301.43	180.97
Long-Term Debt	73	72.3	-	-	-	39.38
Long-Term Unearned Revenue	6.18	6.24	6.48	8.48	10.64	7.2
Long-Term Deferred Tax Liabilities	10.22	12.48	14.62	17.85	41.47	-
Total Liabilities	426.1	426.37	421.37	343.38	353.53	227.55
Common Stock	120	120	120	120	120	120
Additional Paid-In Capital	211.49	211.49	210.29	210.29	212.46	212.46
Retained Earnings	705.74	690.71	656.49	620.17	617.72	346.85
Comprehensive Income & Other	0.72	0.74	0.72	0.11	0.14	0.47
Total Common Equity	1,038	1,023	987.5	950.57	950.33	679.77
Minority Interest	15.16	15.24	-	-	-1.85	-0.8
Shareholders' Equity	1,053	1,038	987.5	950.57	948.48	678.97
Total Liabilities & Equity	1,479	1,465	1,409	1,294	1,302	906.52
Total Debt	315.85	314.74	271	178.15	180.28	170.19
Net Cash (Debt)	-264.61	-268.98	-224.18	-83.09	-64.68	-56.96
Net Cash Per Share	-2.20	-2.24	-1.87	-0.69	-0.54	-0.47
Filing Date Shares Outstanding	120	120	120	120	120	120
Total Common Shares Outstanding	120	120	120	120	120	120
Working Capital	3.9	21.8	-22.97	61.33	0.53	112.77
Book Value Per Share	8.65	8.52	8.23	7.92	7.92	5.66
Tangible Book Value	906.21	882.13	860.73	816.55	828	587.55
Tangible Book Value Per Share	7.55	7.35	7.17	6.80	6.90	4.90
Buildings	-	252.62	251.11	251.11	241.79	229.35
Machinery	-	172.2	227.36	230.08	189.93	184.45
Construction In Progress	-	551.83	381.52	206.08	95.06	21.24

Source: S&P Global Market Intelligence. Standard template. Financial Sources.